CN106366076A - Posaconazole synthesis method - Google Patents

Posaconazole synthesis method Download PDF

Info

Publication number
CN106366076A
CN106366076A CN201610755734.XA CN201610755734A CN106366076A CN 106366076 A CN106366076 A CN 106366076A CN 201610755734 A CN201610755734 A CN 201610755734A CN 106366076 A CN106366076 A CN 106366076A
Authority
CN
China
Prior art keywords
posaconazole
group
acid
reactor
agitator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610755734.XA
Other languages
Chinese (zh)
Other versions
CN106366076B (en
Inventor
殷殿书
魏赛丽
孙曼
印杰
刘玉扑
胡硕
武玉杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Guangxiang Pharmaceutical Technology Co Ltd
Original Assignee
Hebei Guolong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Guolong Pharmaceutical Co Ltd filed Critical Hebei Guolong Pharmaceutical Co Ltd
Priority to CN201610755734.XA priority Critical patent/CN106366076B/en
Publication of CN106366076A publication Critical patent/CN106366076A/en
Application granted granted Critical
Publication of CN106366076B publication Critical patent/CN106366076B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention provides a posaconazole synthesis method which includes the steps: S1, taking a compound displayed by a following formula II as a raw material, taking hydrogen as a hydrogen source, stirring the compound displayed by the formula II, catalysts and acidic reagents in reaction solvents under the hydrogenation debenzylation reaction condition, and performing contact reaction to obtain mixed solution; S2, reducing the temperature of the mixed solution to range from 0 DEG C to 5 DEG C, dropping sodium hydroxide solution into the mixed solution until a pH (potential of hydrogen) value of the mixed solution is 10-12, stirring, filtering to obtain filter cakes, washing the filter cakes, and drying the washed filter cakes to obtain posaconazole as shown in the following formula I.

Description

A kind of synthetic method of posaconazole
Technical field
The present invention relates to pharmaceutical synthesis field, a kind of synthetic method of posaconazole.
Background technology
Posaconazole (Chinese chemical name: 4- [4- [4- [4- [[(3r, 5r) -5- (2,4 difluorobenzene base) -5- (1,2,4- tri- Azoles -1- ylmethyl) oxa- penta ring -3- base] methoxyl group] phenyl] piperazine -1- base] phenyl] -2- [the amyl- 3- of (2s, 3s) -2- hydroxyl Base] -1,2,4- triazole -3- ketone), there is structure shown in following formula i.
Posaconazole is to be developed by German Schering Plough company, and trade name " noxafil ", on October 20th, 2005 in Europe Alliance and U.S. fda get the Green Light the antifungal drug of listing.Posaconazole Oral Suspension obtains the U.S. again in September, 2006 Fda ratifies to weaken for immunity after bone marrow transplantation and causes leukopenic patient with cancer chemotherapy, with prevent aspergillosiss and The microbial infection of beads.Because it has high-efficiency low-toxicity, and clinical application range is wide, and curative effect is preferably, especially right Effectively, the treatment for clinical invasive infections with fungi carries for Polyenes and other triazole type drug resistances or invasive infections with fungi Supply selection space.
With regard to the existing numerous studies of synthetic method of posaconazole in prior art, typically finally by as shown in following formula ii Hydrogenation of compounds debenzylation obtains posaconazole.
Described in us5625064 and cn101824009a: compound shown in formula ii is cooled to 50 DEG C, adds 350ml first Acid, continues cool to 20 DEG C, adds other 350ml methanol, takes 85gpd/c to add 350ml formic acid stirring pulp to add reaction In bottle, it is stirred overnight at 20 DEG C, be heated to 40 DEG C of reaction 24h, sucking filtration, filter cake 350ml formic acid, 700ml methanol drip washing.Subtract Pressure solvent evaporated, adds 3500ml methanol and 700ml ammonia in residue, is heated to the 1-2h that flows back, and then cooling precipitation is big Amount solid, sucking filtration, filter cake is washed with 1400ml first alcohol and water (1:1), and at 40 DEG C, air blast agitation obtains 300.5g end-product.
Anil k.saksena (tetrahedron letters 45 (2004) 8,249 8251) points out: by 4.03g formula ii Described compound is dissolved in 70ml formic acid, adds 5%pd/c 8g, and reactant mixture stirs 15h at 20 DEG C, then heats To 35-40 DEG C, it is stirred for 24h.Then reactant liquor is cooled to 20 DEG C, filters, and wash filter cake with about 40ml formic acid, then use Twice, filtrate revolving, to doing to obtain residue, column chromatography, obtains posaconazole 3g to 35ml methanol washing filter cake, and yield is 84%.
In above-mentioned process, the synthetic route of posaconazole is as follows
In both the above mode, formic acid is reaction dissolvent, is also hydrogen source.First react under 20 °, then rise high-temperature extremely 35-40 DEG C of reaction, total reaction time is all more than 40h, and post processing needs column chromatography purification of samples, and quantity of solvent is too big, is not suitable for Big production.
Described in cn102863431a: add compound (8.12g) and hydrobromic acid shown in formula ii in 250ml there-necked flask 70ml, stirs to solid dissolving, is heated to 50 DEG C of reaction 2-3h, and liquid phase monitoring reaction finishes.Reactant liquor is dilute with water (100ml) Release, naoh aqueous solution (100ml, 25%) adjusts and is about 9 to ph, and dichloromethane (100ml) extracts, and organic faciess 10%naoh are water-soluble Liquid (100ml) washs, and water (100ml) washs, and saturation nacl aqueous solution (100ml) washs, anhydrous naso4It is dried, concentrate, vacuum It is dried, obtains khaki crude product, purity is 93.9%.In this experimental technique, it is also hydrogen source that hydrobromic acid is reaction dissolvent, its There is strong Spina jujubae taste and be difficult to store, easily oxidized.And post processing is loaded down with trivial details, yield is low, is not suitable for being applied to produce greatly.
Additionally, described in wo2013042138a2 and us2014343285a1: add 42g formula ii in 420ml methanol Shown compound, 5mol/l hydrochloric acid and 10%pd-c, in 4-5kg/cm2(0.4-0.5mpa) Hydrogen Vapor Pressure, 50 DEG C of reaction temperature Lower reaction 5h, after reaction terminates, Filtration of catalyst, then adjusting ph value with 4mol/l sodium hydroxide solution is 7 about, plus Enter water and stir 2h at 25-35 DEG C, have a large amount of solids to separate out, filter, and wash filter cake with water, filter cake is tied in isopropanol again Crystalline substance obtains posaconazole, and yield is 75%, and purity is 99.85%.In this process, the synthetic route of posaconazole is as follows:
Although above-mentioned experimental program shortens the response time to a certain extent, improve the purity of mark product.But be It is capable of the large-scale industrial production of posaconazole, synthetic method for posaconazole needs to optimize further And improvement, to establish the posaconazole that a kind of response time is shorter and the purity of posaconazole and yield all increase Synthetic method.
Content of the invention
Present invention is primarily targeted at providing a kind of synthetic method of posaconazole, with the yield improving posaconazole While with purity, provide a kind of synthetic method of the posaconazole being applied to large-scale industrial production.
For this reason, providing a kind of synthetic method of posaconazole in the present invention, this synthetic method comprises the following steps:
S1, with compound as shown in following formula ii as raw material, with hydrogen as hydrogen source, hydrogenation debenzylation under the conditions of, will Compound shown in formula ii stirs haptoreaction with catalyst and acid reagent in reaction dissolvent, obtains mixed solution;
S2, described mixed solution is cooled to 0-5 DEG C, molten to mixing to described mixed solution and dripping sodium hydroxide solution The ph value of liquid is 10-12, and agitation and filtration obtains filter cake, is dried to obtain the posaconazole as shown in following formula i after cleaning.
According to the synthetic method of the present invention, the purpose adding catalyst mainly promotes to hydrogenate debenzylation generation, its In for catalyst using not particular/special requirement, can promote to hydrogenate that debenzylation occurs times using this area The catalyst of meaning.But in order to optimize reaction effect, improve the yield of posaconazole, 10% preferably with water content as 50wt% Palladium-carbon catalyst is as the catalyst (catalysis of the 10wt% that wherein 10% palladium-carbon catalyst is catalyst butt weight for palladium content Agent), and the dry weight of described 10wt% palladium-carbon catalyst is (0.05-0.1) with the weight ratio of compound shown in formula ii: 1, preferably (0.08-1): 1, more preferably 0.08:1.
According to the synthetic method of the present invention, the main purpose adding acid reagent is in order that formula ii is dissolved in reaction dissolvent In, wherein for acid reagent using not particular/special requirement, can be this area conventional arbitrarily disclosure satisfy that above-mentioned mesh Organic acid or mineral acid.But in order to optimize reaction effect, improve the yield of posaconazole, preferably described acid reagent with The envelope-bulk to weight ratio of compound shown in formula ii is (0.5-1.5) l:1kg, more preferably 1l:1kg.
Preferably, described acid reagent is hydrochloric acid, sulphuric acid, and one or more of glacial acetic acid, formic acid and benzenesulfonic acid are more excellent Described acid reagent is selected to be hydrochloric acid.Concentration for these acid reagents does not have particular/special requirement in the present invention, can basis It is actually needed adjustment.
Synthetic method according to the present invention, it is preferred that emphasis is with compound shown in formula ii as raw material, with hydrogen for hydrogen source in hydrogen It is stirred under the conditions of changing debenzylation reacting, and then while accelerating reaction efficiency, improve the yield of posaconazole, and Simplify post-processing step.Do not have particular/special requirement, Ke Yican for hydrogenation debenzylation condition in step s1 in the present invention Corresponding conditionses in the synthetic method of more solito, in the present invention preferably described hydrogenation debenzylation condition include: normal pressure, Under the conditions of temperature is 50-55 DEG C, with the speed of 350-450rpm, stirring reaction 2-3h.
According to the synthetic method of the present invention, in order to meet the requirement of stirring reaction in step s1, under preferable case, promote to walk Rapid s1 is carried out in the reactor be built-in with agitator.This reactor being built-in with agitator can adopt the anti-of conventional commercial Answer kettle.But in order to optimize mixing effect, promote material to carry out conducting heat in the case of stirring, mass transfer and reaction, and then improve Reaction rate, in a preferred embodiment, in described reactor, agitator includes shaft and the axle along described shaft The uniform multigroup stirring vane group in line direction, is included in each stirring vane group respectively along described shaft circumference uniform 1 to 3 Piece stirring vane.Preferably, stirring vane parallel arrangement or staggered in two adjacent groups stirring vane group.Preferably described Stirring vane is 1/5-2/5 times of described stirred tank radius along the length of described reactor radial direction, preferably 1/3 times.
According to the synthetic method of the present invention, in order to optimize mixing effect further, reaction is promoted to accelerate, preferably described reaction It is additionally provided with least one set baffle group, described one group of baffle group includes multiple baffle plates and the length direction of each described baffle plate in kettle Arrange along the axis direction setting parallel to described agitator, width along the radial direction of described reactor.Preferably described Agitator is along the axis setting of described reactor, and in described one group of baffle group, each described baffle plate with the axis of described agitator is Vertically middle separated time is circumferentially distributed.The height of preferably each described baffle plate is 1/2-2/3 times of stirred tank height, and width is described 1/6-1/4 times of stirred tank radius, thickness is 0.5-1cm.By arranging baffle group in stirred tank, promote to be stirred by agitator Liquid impact with baffle plate, promote compound and hydrogen, catalyst and acid reagent shown in formula ii in the situation of stirring Under carry out conducting heat, mass transfer and reaction, and then improve reaction efficiency.
In a preferred embodiment, it is provided with one group of baffle group in described reactor, and each baffle plate edge in this baffle group The direction that its width extends, side is fixed on the inwall of described reactor, and opposite side extends towards the position of described agitator.
In another kind of preferred implementation, two groups or three groups of baffle group, each described baffle group are set in described reactor Axis with described agitator be vertically middle separated time be in concentric circular arrange and two adjacent groups baffle group in baffle plate be crisscross arranged.
According to the synthetic method of the present invention, in step s2, described mixed solution is cooled to 0-5 DEG C, right in this step Do not have particular/special requirement in selected cooling method, in mixed solution, preferably directly add ice cube in the present invention to carry out Fast cooling, this fast cooling can reduce the generation of side reaction.
In a preferred embodiment, comprised the following steps according to the synthetic method of the present invention: s1, with such as following formula ii Shown compound is raw material, with hydrogen as hydrogen source, by compound shown in formula ii, 10% palladium-carbon catalyst and acid reagent in proportion (concrete ratio, with reference to preceding description, will not be described here) stirring mixing in a kettle., at a temperature of normal pressure, 50-55 DEG C, with The speed of 350-450rpm, stirring reaction 2-3h (hplc monitoring reaction, control reaction end), mixed after separating catalyst Solution;Wherein said reactor be built-in with agitator and optional least one set baffle group reactor (described agitator and The structure of described baffle group will not be described here as previously mentioned);S2, described mixed solution is cooled to 0-5 DEG C, to described mixing In solution, Deca alkaline reagent is 10-12 to the ph value of mixed solution, and agitation and filtration obtains filter cake, is dried to obtain as following formula after cleaning Posaconazole shown in i.
According to the synthetic method of the present invention, the wherein method for compound shown in formula ii of acquisition does not have particular/special requirement, It synthesizes according to conventional method of the prior art, for example: in 100ml there-necked flask add 2- [(1s, 2s) -1- ethyl - 2- benzyloxy propyl group] -2,4- dihydro -4- [4- [4- (4- hydroxy phenyl) -1- piperazinyl] phenyl] -3h-1,2,4- triazole -3- Ketone (4.78g) and dmso (40ml), stirring and dissolving, add the naoh aqueous solution (1.6ml) of concentration 25wt%, 10 points of mix and blend Clock, adds (5r-cis)-toluene-4-sulfonic acid 5- (2,4 difluorobenzene base) -5- (1h-1,2,4- triazole -1- bases) methyl tetrahydrochysene Furan -3- ylmethyl ester (4.4g), 30 DEG C of reaction about 14h of mixture, liquid phase is monitored and is finished to reaction, reactant liquor is poured into acutely In the water (240ml) of stirring, finish, be vigorously agitated again 10min, filter, filter cake washes with water, by filter cake recrystallisation from isopropanol After obtain solid, vacuum drying obtains pale powder solid (formula ii).
Meanwhile, additionally provide a kind of posaconazole being synthesized by method of the present invention in the present invention, preferably described Purity >=99% of posaconazole.
Synthetic method according to posaconazole provided by the present invention compound shown in formula ii as raw material, with hydrogen as hydrogen Source, promotes compound shown in formula ii that hydrogenation debenzylation occurs under agitation.The method not only reduce reaction for The requirement of pressure, and substantially shorten the response time, only need 2-3h;And post processing is easy, low temperature section ph value To 10-12, it is centrifuged, you can obtain target product posaconazole, the method is applied to large-scale industrial production.
Brief description
Accompanying drawing is used to provide a further understanding of the present invention, and constitutes the part of description, with following tool Body embodiment is used for explaining the present invention together, but is not construed as limiting the invention.In the accompanying drawings:
Fig. 1 is the nucleus magnetic hydrogen spectrum figure of the posaconazole synthesized by embodiment 1;
Fig. 2 is the nuclear-magnetism carbon spectrogram of the posaconazole synthesized by embodiment 1.
Specific embodiment
Shown in formula ii employed in embodiment 1 to 4, the synthetic method of the compound of structure is as follows:
2- [(1s, 2s) -1- ethyl -2- benzyloxy propyl group] -2,4- dihydro -4- [4- [4- is added in 100ml there-necked flask (4- hydroxy phenyl) -1- piperazinyl] phenyl] -3h-1,2,4- triazoles -3- ketone (4.78g) and dmso (40ml), stirring and dissolving, Add the naoh aqueous solution (1.6ml) of concentration 25wt%, mix and blend 10 minutes, add (5r-cis)-toluene-4-sulfonic acid 5- (2,4 difluorobenzene base) -5- (1h-1,2,4- triazole -1- bases) methyltetrahydrofuran -3- ylmethyl ester (4.4g), mixture 30 DEG C reaction about 14h, liquid phase is monitored and is finished to reaction, reactant liquor is poured in the water (240ml) being stirred vigorously, finishes, more acutely Stirring 10min, filters, and filter cake washes with water, will obtain solid after filter cake recrystallisation from isopropanol, and vacuum drying obtains canescence Powder solid (formula ii);Understand through nuclear-magnetism, mass spectrum and infrared spectrum comprehensive detection, this Lycoperdon polymorphum Vitt powder solid is to change described in formula ii Compound, and the purity of this compound is > 99%.
Embodiment 1
For illustrate posaconazole of the present invention and its synthetic method
(1) it is built-in with the reactor structure of agitator:
The height of this reactor is 120cm, the 100l enamel reaction still of a diameter of 50cm.It is provided with agitator and one group Baffle group, described agitator be standard configuration, including along described reactor axis direction setting shaft and along described shaft The uniform two groups of group stirring vane groups of axis direction, each group stirring vane group be arranged in parallel, and wraps in every group of stirring vane group Include two panels along the described shaft uniform stirring vane of circumference, every stirring vane is along the length of described reactor radial direction 8cm;It is 60cm that described baffle group includes height, and width is 5cm, and thickness is 4 baffle plates of 1cm, the length direction edge of each baffle plate Axis direction parallel to described agitator arranges (side is fixed on the diapire of described reactor), width along described anti- The radial direction answering kettle is arranged, and the direction that each baffle plate extends along its width is (on the side wall that side is fixed on described reactor, another Side extends towards the position of described agitator), and each baffle plate is circumferentially distributed with the axis of described agitator for vertically middle separated time.
(2) synthesis of posaconazole
Add 60l methanol, compound shown in 4kg formula ii in above-mentioned 100l enamel reaction still, 4l concentration is 36.5wt% Hydrochloric acid, ((mixing speed is turn on agitator 10% palladium-carbon catalyst of 320g for aqueous 50%), sealed reactor 350rpm).First use air 3 times in nitrogen displacement kettle, then with hydrogen exchange 3 times, Hydrogen Vapor Pressure is maintained at 0.1mpa (gauge pressure), liter Temperature is heated to 50 DEG C, hplc monitoring reaction, and 2h reaction terminates.Cooling, with nitrogen displacement 3 times, is filtrated to get 10% palladium carbon catalysis Agent.Filtrate is poured in another 200l enamel reaction still, adds ice cube, be cooled to 0-5 DEG C, Deca 2mol/l in filtrate Naoh solution, adjusts ph to 11, has a large amount of solids to separate out, after stirring 2h, centrifugation, and wash filter cake 3 times with water, solid is put in It is dried in 55 DEG C of air dry ovens, obtain the product of 3.32kg, accompanying drawing 1 shows the nucleus magnetic hydrogen spectrum figure of this product, accompanying drawing 2 illustrates The nuclear-magnetism carbon spectrogram of this product, understands, this product is exactly what is needed posaconazole, be computed the receipts of this product in conjunction with attached Fig. 1 and 2 Rate is 93.6%, hplc purity is 99.754%.
Embodiment 2
For illustrate posaconazole of the present invention and its synthetic method
(1) it is built-in with the reactor structure of agitator: with embodiment 1.
(2) synthesis of posaconazole:
The enamel reaction still of aforementioned 100l adds, adds 60l methanol, compound shown in 4kg formula ii, 6l concentration is The sulphuric acid of 98wt%, ((mixing speed is turn on agitator 10% palladium-carbon catalyst of 400g for aqueous 50%), sealed reactor 400rpm).First use air 3 times in nitrogen displacement kettle, then with hydrogen exchange 3 times, Hydrogen Vapor Pressure is maintained at 0.1mpa (gauge pressure), liter Temperature is heated to 55 DEG C, hplc monitoring reaction, and 2h reaction terminates.Cooling, with nitrogen displacement 3 times, is filtrated to get 10% palladium carbon catalysis Agent.Filtrate is poured in another 200l enamel reaction still, adds ice cube, be cooled to 0-5 DEG C, Deca 2mol/l in filtrate Naoh solution, adjusts ph to 12, has a large amount of solids to separate out, after stirring 2h, centrifugation, and wash filter cake 3 times with water, solid is put in It is dried in 55 DEG C of air dry ovens, obtain the product of 3.27kg, by nucleus magnetic hydrogen spectrum figure nuclear-magnetism carbon spectrogram, this product is exactly Required posaconazole, the yield being computed this product is 99.594wt% for 92.3%, hplc purity.
Embodiment 3
For illustrate posaconazole of the present invention and its synthetic method
(1) it is built-in with the reactor structure of agitator: with embodiment 1;
(2) synthesis of posaconazole:
The enamel reaction still of aforementioned 100l adds, adds 60l methanol, compound shown in 4kg formula ii, 4l concentration is The hydrochloric acid of 36.5wt%, 10% palladium-carbon catalyst (aqueous 50%), sealed reactor, the turn on agitator (mixing speed of 200g For 450rpm).First use air 3 times in nitrogen displacement kettle, then with hydrogen exchange 3 times, Hydrogen Vapor Pressure is maintained at 0.12mpa, intensification It is heated to 50 DEG C, hplc monitoring reaction, 3h reaction terminates.Cooling, with nitrogen displacement 3 times, is filtrated to get 10% palladium-carbon catalyst (standby).Filtrate is poured in another 200l enamel reaction still, adds ice cube, be cooled to 0-5 DEG C, the Deca in filtrate 2mol/l na2co3Solution, adjusts ph to 10, has a large amount of solids to separate out, after stirring 2h, centrifugation, and wash filter cake 3 times with water, will Solid is put in 55 DEG C of air dry ovens and is dried, and obtains the product of 3.24kg, by nucleus magnetic hydrogen spectrum figure nuclear-magnetism carbon spectrogram, should Product is exactly what is needed posaconazole, and the yield being computed this product is 99.125% for 91.4%, hplc purity.
Embodiment 4
For illustrate posaconazole of the present invention and its synthetic method
(1) it is built-in with the reactor structure of agitator: the height of this reactor is 120cm, the 100l of a diameter of 50cm wards off Porcelain reactor.It is provided with agitator (not baffled), described agitator includes the axis direction setting along described reactor Shaft and along four groups of uniform stirring vane groups of the axis direction of described shaft, each group stirring vane group be arranged in parallel, and Every group of stirring vane group includes 3 along the uniform stirring vane of described shaft circumference, and stirring vane is along described reactor footpath Length 8cm to direction.
(2) synthesis of posaconazole: the synthesis of posaconazole in reference embodiment, the reacted product obtaining 3.19kg, By nucleus magnetic hydrogen spectrum figure nuclear-magnetism carbon spectrogram, this product is exactly what is needed posaconazole, and the yield being computed this product is 90.1%, hplc purity is 98.565%.
It can be seen that the compound using method of the present invention synthesis type (i) is easy easily from the result of above-described embodiment OK, and reaction efficiency is high and yield is high.And, as described above, in us5625064 and cn101824009a, report technical side Method needs to react 40h;Though the report technology response time is 5h in wo2013042138a2 and us2014343285a1, target is produced Thing purity after recrystallisation from isopropanol just reaches 99.85%;Report in cn102863431a that the post processing of technical method is too numerous Trivial, and purity too low (93.9%).The present invention passes through with hydrogen as hydrogen source, in stirring condition (setting agitator and optional gear Plate) under complete to hydrogenate debenzylation hence it is evident that shortening the response time (2-3h), and post processing is easy, purity height (> 98.5%).The expelling pathogens by strengthening vital QI that the method for the present invention overcomes prior art replaces the synthesis process in cloth synthetic method complicated, produces The defect of cycle length, is suitable for large-scale industrial production.And, in the subsequent treatment process of synthesis posaconazole, utilize The method of the invention synthesis can reduce the introducing of impurity, is conducive to the application in pharmaceutical field.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for the skill of this area For art personnel, the present invention can have various modifications and variations.All within the spirit and principles in the present invention, made any repair Change, equivalent, improvement etc., should be included within the scope of the present invention.

Claims (10)

1. a kind of synthetic method of posaconazole is it is characterised in that the synthetic method of described posaconazole comprises the following steps:
S1, with compound as shown in following formula ii as raw material, with hydrogen as hydrogen source, hydrogenation debenzylation under the conditions of, will be described Compound shown in formula ii stirs haptoreaction with catalyst and acid reagent in reaction dissolvent, obtains mixed solution;
S2, described mixed solution is cooled to 0-5 DEG C, to described mixed solution and dripping sodium hydroxide solution to mixed solution Ph value is 10-12, and agitation and filtration obtains filter cake, is dried to obtain the posaconazole as shown in following formula i after cleaning,
2. method according to claim 1 it is characterised in that in described step s1 catalyst be water content be 50wt% 10wt% palladium-carbon catalyst, and water content be 50wt% 10wt% palladium-carbon catalyst with the weight ratio of compound shown in formula ii be (0.05-0.1): 1, preferably (0.08-1): 1, more preferably 0.08:1.
3. method according to claim 1 it is characterised in that acid reagent described in described step s1 be mineral acid and/ Or organic acid, preferably described acid reagent is (0.5-1.5) l:1kg with the envelope-bulk to weight ratio of compound shown in formula ii, more preferably For 1l:1kg.
4. method according to claim 1 includes it is characterised in that hydrogenating debenzylation condition in described step s1: Under conditions of normal pressure, temperature are 50-55 DEG C, with the speed of 350-450rpm, stirring reaction 2-3h.
5. method according to claim 1 is it is characterised in that described step s1 is entered in the reactor be built-in with agitator OK.
6. method according to claim 5 it is characterised in that in described reactor agitator include shaft and along described The uniform multigroup stirring vane group of the axis direction of shaft, is included in each stirring vane group respectively along described shaft circumference 1 to 3 uniform stirring vane.
7. the method according to claim 5 or 6 is it is characterised in that be additionally provided with least one set baffle group in described reactor, Described one group of baffle group includes the length direction of multiple baffle plates and each described baffle plate along the axis side parallel to described agitator Arrange to setting, width along the radial direction of described reactor;
Preferably described agitator is along the axis setting of described reactor, and in described one group of baffle group, each described baffle plate is stirred with described The axis mixing device is that vertically middle separated time is circumferentially distributed.
8. method according to claim 7 it is characterised in that
It is provided with one group of baffle group, and the direction that in this baffle group, each baffle plate extends along its width, side is fixed in described reactor On the inwall of described reactor, opposite side extends towards the position of described agitator;Or
Two groups or three groups of baffle group are set in described reactor, and each described baffle group is with the axis of described agitator in vertical point Line is in that the baffle plate in concentric circular setting and two adjacent groups baffle group is crisscross arranged.
9. method according to claim 1 it is characterised in that described acid reagent be hydrochloric acid, sulphuric acid, glacial acetic acid, formic acid One or more of with benzenesulfonic acid, preferably described acid reagent is hydrochloric acid.
10. the posaconazole that in a kind of claim 1 to 9, the method synthesis described in any one obtains, preferably described pool sand health Purity >=99% of azoles.
CN201610755734.XA 2016-08-29 2016-08-29 A kind of synthetic method of posaconazole Active CN106366076B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610755734.XA CN106366076B (en) 2016-08-29 2016-08-29 A kind of synthetic method of posaconazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610755734.XA CN106366076B (en) 2016-08-29 2016-08-29 A kind of synthetic method of posaconazole

Publications (2)

Publication Number Publication Date
CN106366076A true CN106366076A (en) 2017-02-01
CN106366076B CN106366076B (en) 2019-07-16

Family

ID=57901841

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610755734.XA Active CN106366076B (en) 2016-08-29 2016-08-29 A kind of synthetic method of posaconazole

Country Status (1)

Country Link
CN (1) CN106366076B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106883221A (en) * 2017-04-17 2017-06-23 兰州大学 A kind of amorphous posaconazole and preparation method thereof
CN109970725A (en) * 2019-03-29 2019-07-05 武汉朗来科技发展有限公司 The preparation method of posaconazole
CN112824400A (en) * 2019-11-20 2021-05-21 华创合成制药股份有限公司 Preparation method of posaconazole
WO2023122868A1 (en) * 2021-12-27 2023-07-06 浙江海正药业股份有限公司 Posaconazole impurity reference substance and preparation method therefor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013042138A2 (en) * 2011-09-19 2013-03-28 Msn Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
CN104761555A (en) * 2015-03-21 2015-07-08 河北国龙制药有限公司 Tofacitinib intermediate preparation method and method for preparing tofacitinib or its salt by using tofacitinib intermediate preparation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013042138A2 (en) * 2011-09-19 2013-03-28 Msn Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
CN104761555A (en) * 2015-03-21 2015-07-08 河北国龙制药有限公司 Tofacitinib intermediate preparation method and method for preparing tofacitinib or its salt by using tofacitinib intermediate preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张秋荣等: "《制药工艺学》", 31 August 2007 *
陈乙崇: "《搅拌设备设计》", 30 November 1985 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106883221A (en) * 2017-04-17 2017-06-23 兰州大学 A kind of amorphous posaconazole and preparation method thereof
CN109970725A (en) * 2019-03-29 2019-07-05 武汉朗来科技发展有限公司 The preparation method of posaconazole
CN112824400A (en) * 2019-11-20 2021-05-21 华创合成制药股份有限公司 Preparation method of posaconazole
WO2023122868A1 (en) * 2021-12-27 2023-07-06 浙江海正药业股份有限公司 Posaconazole impurity reference substance and preparation method therefor

Also Published As

Publication number Publication date
CN106366076B (en) 2019-07-16

Similar Documents

Publication Publication Date Title
CN106366076A (en) Posaconazole synthesis method
CN110194776A (en) A kind of synthetic method of Rui Lugeli
CN102241679B (en) Process for the synthesis of 4h-imidazo [1,5-a] [1,4] benzodiazepines, in particular midazolam and salts thereof
CN108947891B (en) Method for safely preparing pimavanserin and tartrate thereof by using triphosgene
CN108794351B (en) Preparation method of pimavanserin key intermediate
CN105566215B (en) A kind of Rui Gefeini preparation method
CN103554201B (en) Gamithromycin preparation method
CN106046004A (en) Total synthesis method for theacrine
CN103254201B (en) A kind of preparation method of asenapine
CN107235959A (en) A kind of novel method for synthesizing for preparing cancer therapy drug Niraparib
CN107383017A (en) Buddhist nun's high efficiency preparation method is replaced according to Shandong
CN106699570A (en) Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone
CN103483324B (en) The new preparation process of lapatinibditosylate
CN103509025A (en) Preparation method of epinastine hydrochloride and intermediate thereof
CN101792387B (en) Preparation method of 2,3,4-trimethoxybenzoic acid
CN106946880A (en) A kind of method for preparing Rui Boxini intermediates
CN103709174B (en) The one-step synthesis of the bromo-3H-oxazole of 6-also [4,5-b] pyridin-2-ones
CN109810066A (en) A kind of synthetic method of the ambroxol hydrochloride in relation to substance
CN106349229B (en) The preparation method and midbody compound of Lei Dipawei intermediates
CN113620957B (en) Preparation method of aminomethyl pyrazine compound
CN107325055A (en) A kind of synthetic method of olaparib compound
CN105175316B (en) A kind of method for preparing laxative picosulfate sodium
CN104230790B (en) A kind of Sitafloxacin side chain Intermediate Preparation method
CN114685401A (en) Synthesis method of di (4-methylpiperazine-1-yl) ketone
CN104387385B (en) 6-carboxylate methyl ester-2-oxygen-7-azaindole and preparation method thereof and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20200603

Address after: 061100 West Zone and east side of Jingliu Road, Lingang Economic and Technological Development Zone, Cangzhou City, Hebei Province

Patentee after: HEBEI GUANGXIANG PHARMACEUTICAL Co.,Ltd.

Address before: 052165, Hebei, Shijiazhuang Shijiazhuang economic and Technological Development Zone, Yang Zi Road, Societe Generale Road West

Patentee before: HEBEI GUOLONG PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right